Insider screener

Period: 12 months Plan: Scheduled (10b5-1) × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

23,219 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

23,219 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

23,219 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

23,219 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
23,219 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
23,219 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

23,219 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
2 Mar 2026
OASHEIM JARED CHIEF FINANCIAL OFFICER
Sold on a plan
$13.78K 1,744 at 7.90
1.8%
Planned (10b5-1)
2 Mar 2026
Boyle Dana Chief Accounting Officer
Sold on a plan
$13.61K 445 at 30.58
0.2%
Planned (10b5-1)
2 Mar 2026
Zamansky Dmitry Chief Product & Tech. Officer
Sold on a plan
$13.47K 2,472 at 5.45
1.2%
Planned (10b5-1)
2 Mar 2026
CHORMAN THOMAS E Director
Sold on a plan
$12.95K 50 at 259.00
0.4%
Planned (10b5-1)
2 Mar 2026
Epstein David R Director
Sold on a plan
$12.67K 250 at 50.69
1.0%
Planned (10b5-1)
2 Mar 2026
Grimmig Andrew E Chief Legal Officer
Sold on a plan
$10.31K 1,000 at 10.31
1.0%
Planned (10b5-1)
2 Mar 2026
Mirgorodskaya Natalia See Remarks
Sold on a plan
$10.15K 390 at 26.02
1.1%
Planned (10b5-1)
2 Mar 2026
VERRASTRO PAUL CHIEF MKTG & STRAT OFFICER
Sold on a plan
$10.15K 1,284 at 7.90
2.1%
Planned (10b5-1)
2 Mar 2026
Adamson Philip B. Chief Medical Officer
Sold on a plan
$9.97K 1,262 at 7.90
2.0%
Planned (10b5-1)
2 Mar 2026
Kerdman Alina SVP, Controller & CAO
Sold on a plan
$9.54K 151 at 63.16
19.5%
Planned (10b5-1)
2 Mar 2026
Krepp Sarah Chief Human Resource Officer
Sold on a plan
$8.44K 276 at 30.58
0.2%
Planned (10b5-1)
2 Mar 2026
Gebert Richard D Director
Sold on a plan
$8.24K 500 at 16.47
1.3%
Planned (10b5-1)
2 Mar 2026
Afsari Nasym General Counsel and Secretary
Sold on a plan
$6.00K 200 at 30.00
0.1%
Planned (10b5-1)
2 Mar 2026
Stith Kimberly G. SVP - Chief HR Officer
Sold on a plan
$5.11K 21 at 243.13
0.4%
Planned (10b5-1)
2 Mar 2026
Reed David L. EVP & CFO
Sold on a plan
$5.10K 21 at 242.65
0.2%
Planned (10b5-1)
2 Mar 2026
O'Dowd William IV Chief Executive Officer
Bought on a plan
$4.99K 3,100 at 1.61
0.7%
Bought on a plan
2 Mar 2026
Sklar James Edward EVP, Gen Counsel & Secretary
Sold on a plan
$4.85K 3,734 at 1.30
1.4%
Planned (10b5-1)
2 Mar 2026
Freemen-Bosworth Lauren EVP/Gen Counsel & Corp Sec
Sold on a plan
$2.87K 271 at 10.60
0.9%
Planned (10b5-1)
2 Mar 2026
Conkling Lori A Director
Bought on a plan
$1.73K 25 at 69.21
1.0%
Bought on a plan
2 Mar 2026
McCallion Kevin J. SVP, Products and Production
Sold on a plan
$49.00 7 at 7.00
0.0%
Planned (10b5-1)
27 Feb 2026
INNOVEX CO-INVEST FUND, L.P. Director · indirect
Sold on a plan 6×
$162.61M 6,612,500 at 24.59
100.0%
Sold half or more
27 Feb 2026
LI SUSAN J Chief Financial Officer · indirect
Sold on a plan 10×
$36.47M 56,571 at 644.70
100%
Sold half or more
27 Feb 2026
Kewalramani Reshma CEO & President
Sold on a plan 13×
$19.74M 40,000 at 493.47
28.9%
Planned (10b5-1)
27 Feb 2026
Bought on a plan
$10.53M 147,000 at 71.63
0.3%
Bought on a plan
27 Feb 2026
Pate R. Hewitt Chief Legal Officer
Sold on a plan 4×
$6.60M 35,475 at 186.06
80.6%
Sold half or more
27 Feb 2026
Neumann Spencer Adam Chief Financial Officer
Sold on a plan 2×
$5.47M 57,260 at 95.50
43.7%
Planned (10b5-1)
27 Feb 2026
BONNER EIMEAR P Chief Financial Officer
Sold on a plan 4×
$5.28M 28,400 at 186.06
77.1%
Sold half or more
27 Feb 2026
Ali Wajid EVP & CHIEF FINANCIAL OFFICER
Sold on a plan 13×
$3.66M 5,302 at 691.13
7.4%
Planned (10b5-1)
27 Feb 2026
CREMERS ERIC J Executive Chairman
Sold on a plan
$3.63M 169,200 at 21.44
19.3%
Planned (10b5-1)
27 Feb 2026
JANNEY DANIEL Director · indirect
Sold on a plan 2×
$3.25M 11,803 at 275.59
13.9%
Planned (10b5-1)
27 Feb 2026
Rabiller Olivier President & CEO
Sold on a plan
$2.93M 144,000 at 20.32
13.7%
Planned (10b5-1)
27 Feb 2026
ROBINS CHAD M CEO and Chairman
Sold on a plan
$2.92M 182,891 at 15.99
7.4%
Planned (10b5-1)
27 Feb 2026
Mat Ishbia President and CEO · indirect
Sold on a plan
$2.81M 632,874 at 4.44
23.5%
Planned (10b5-1)
27 Feb 2026
Wu Lei Chief Executive Officer · indirect
Sold on a plan 5×
$2.61M 60,000 at 43.57
9.9%
Planned (10b5-1)
27 Feb 2026
Huffman Steve Ladd CEO & President · indirect
Sold on a plan 7×
$2.61M 18,000 at 145.12
4.2%
Planned (10b5-1)
27 Feb 2026
Valantine Hannah Director
Sold on a plan 2×
$1.72M 25,484 at 67.41
77.3%
Sold half or more
27 Feb 2026
Garg Pushkal EVP Chief R&D
Sold on a plan 5×
$1.53M 4,627 at 331.34
17.3%
Planned (10b5-1)
27 Feb 2026
O'Day Daniel Patrick Chairman & CEO
Sold on a plan 3×
$1.45M 10,000 at 144.79
1.5%
Planned (10b5-1)
27 Feb 2026
Mansueto Joseph D Executive Chairman
Sold on a plan 3×
$1.32M 7,250 at 181.60
0.1%
Planned (10b5-1)
27 Feb 2026
ROEDER ROSHAN S CVP & Pres. Mission Systems
Sold on a plan
$1.26M 1,754 at 720.00
42.7%
Planned (10b5-1)
27 Feb 2026
Curet Myriam EVP & Chief Medical Officer · indirect
Sold on a plan
$1.17M 2,345 at 499.71
85.1%
Sold half or more
27 Feb 2026
Baszucki Gregory Director · indirect
Sold on a plan 6×
$1.15M 16,666 at 68.98
1.3%
Planned (10b5-1)
27 Feb 2026
Bozic Carmen EVP and CMO
Sold on a plan
$1.12M 2,329 at 480.31
5.8%
Planned (10b5-1)
27 Feb 2026
Makagon Kira President and COO
Sold on a plan 2×
$780.28K 22,196 at 35.15
6.1%
Planned (10b5-1)
27 Feb 2026
Jackson Benjamin President
Sold on a plan
$637.73K 3,865 at 165.00
2.3%
Planned (10b5-1)
27 Feb 2026
Campion Michele Chief Human Resources Officer
Sold on a plan 2×
$624.93K 5,096 at 122.63
31.3%
Planned (10b5-1)
27 Feb 2026
Rodgers Mark C MD, Africa-Asia Pacific
Sold on a plan
$577.59K 4,443 at 130.00
13.8%
Planned (10b5-1)
27 Feb 2026
Ulrich Phillip R. Executive Vice President
Sold on a plan
$542.32K 4,106 at 132.08
8.9%
Planned (10b5-1)
27 Feb 2026
Burke Desiree A. CFO and Treasurer
Sold on a plan
$480.59K 9,804 at 49.02
7.1%
Planned (10b5-1)
27 Feb 2026
Sold on a plan
$432.00K 12,000 at 36.00
6.9%
Planned (10b5-1)
Showing 15,851–15,900 of 23,219. ← Newer Page 318 of 465 Older →